Healthcare provider profile · identity verified

Mark R Bradley, D.O.

Family Practice · HARTFORD, WI · NPI 1427016575

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	163
Levothyroxine Sodium	Levothyroxine Sodium	311	85
Rosuvastatin Calcium	Rosuvastatin Calcium	310	96
Metoprolol Succinate	Metoprolol Succinate	293	87
Lisinopril	Lisinopril	270	80
Pantoprazole Sodium	Pantoprazole Sodium	229	74
Amlodipine Besylate	Amlodipine Besylate	219	66
Losartan Potassium	Losartan Potassium	209	58
Tamsulosin Hcl	Tamsulosin Hcl	204	58
Gabapentin	Gabapentin	181	65
Omeprazole	Omeprazole	181	59
Oxycodone Hcl	Oxycodone Hcl	166	28
Simvastatin	Simvastatin	150	46
Alprazolam	Alprazolam	146	30
Montelukast Sodium	Montelukast Sodium	143	38
Albuterol Sulfate Hfa	Albuterol Sulfate	122	42
Allopurinol	Allopurinol	121	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	31
Metformin Hcl Er	Metformin Hcl	120	41
Metformin Hcl	Metformin Hcl	115	30
Furosemide	Furosemide	114	38
Eliquis	Apixaban	113	31
Hydrochlorothiazide	Hydrochlorothiazide	107	35
Meloxicam	Meloxicam	105	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	100	31
Trazodone Hcl	Trazodone Hcl	96	28
Warfarin Sodium	Warfarin Sodium	93	24
Zolpidem Tartrate	Zolpidem Tartrate	92	21
Tramadol Hcl	Tramadol Hcl	91	25
Finasteride	Finasteride	90	28
Escitalopram Oxalate	Escitalopram Oxalate	89	32
Metoprolol Tartrate	Metoprolol Tartrate	88	28
Lorazepam	Lorazepam	84	22
Ezetimibe	Ezetimibe	82	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	81	24
Pravastatin Sodium	Pravastatin Sodium	81	23
Duloxetine Hcl	Duloxetine Hcl	67	19
Fluticasone Propionate	Fluticasone Propionate	66	37
Ozempic	Semaglutide	63	14
Clopidogrel	Clopidogrel Bisulfate	60	14
Fluoxetine Hcl	Fluoxetine Hcl	59	16
Atenolol	Atenolol	58	19
Sertraline Hcl	Sertraline Hcl	58	21
Glimepiride	Glimepiride	57	19
Clonazepam	Clonazepam	50	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	27
Potassium Chloride	Potassium Chloride	49	15
Jardiance	Empagliflozin	47	13
Citalopram Hbr	Citalopram Hydrobromide	46	13
Pregabalin	Pregabalin	46	13
Fentanyl	Fentanyl	45	suppressed
Spironolactone	Spironolactone	45	16
Bupropion Xl	Bupropion Hcl	44	16
Olmesartan Medoxomil	Olmesartan Medoxomil	44	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	11
Memantine Hcl	Memantine Hcl	41	13
Oxybutynin Chloride Er	Oxybutynin Chloride	40	13
Celecoxib	Celecoxib	39	14
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Diclofenac Sodium	Diclofenac Sodium	36	16
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Diazepam	Diazepam	33	15
Donepezil Hcl	Donepezil Hcl	33	suppressed
Prednisone	Prednisone	33	25
Tizanidine Hcl	Tizanidine Hcl	33	15
Carvedilol	Carvedilol	32	12
Amitriptyline Hcl	Amitriptyline Hcl	31	11
Clonidine Hcl	Clonidine Hcl	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	14
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Azithromycin	Azithromycin	27	24
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Famotidine	Famotidine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Xarelto	Rivaroxaban	24	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Topiramate	Topiramate	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	13
Farxiga	Dapagliflozin Propanediol	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Colchicine	Colchicine	20	11
Glipizide Er	Glipizide	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Xtampza Er	Oxycodone Myristate	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Amoxicillin	Amoxicillin	15	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	15	suppressed
Anastrozole	Anastrozole	14	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Cephalexin	Cephalexin	11	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error